Gabas Jr, Elpidio G.

HRN: 05-16-06  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/01/2024
09/07/2024
IV
500mg
Q8H
Acute Infectious Diarrhea
Waiting Final Action 
09/02/2024
CEFTRIAXONE 1G (VIAL)
09/02/2024
09/08/2024
IV
2g
OD
Acute Infectious Diarrhea; T/c UTI
Waiting Final Action 
09/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/09/2024
09/15/2024
IVTT
500 Mg
Q6
Hepatic Abscess
Waiting Final Action 
09/13/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/13/2024
09/20/2024
IV
4.5g
Q6
Post Op Exlap
Waiting Final Action 
09/13/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/13/2024
09/20/2024
IV
500mg
Q8
Post Op Exlap
Waiting Final Action 
09/22/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/22/2024
09/29/2024
IV
4.5g
Q6
Liver Abscess, Post Op Exlap
Waiting Final Action 
09/23/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/23/2024
09/30/2024
IV
4.5g
Q6
Liver Abscess
Waiting Final Action 
09/23/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/23/2024
10/07/2024
IV
4.5g
Q6
Liver Abscess
Waiting Final Action 
09/23/2024
CIPROFLOXACIN 500MG (TAB)
09/23/2024
09/30/2024
PO
500 Mg
BID
Hepatic Abscess
Waiting Final Action 
09/23/2024
METRONIDAZOLE 500MG (TAB)
09/23/2024
10/03/2024
PO
750 Mg
Every 8hr
Liver Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: